p16INK4A as a predictive factor in patients with locally advanced breast cancer treated with neoadjuvant doxorubicin monotherapy

p16INK4A as a predictive factor in patients with locally advanced breast cancer treated with neoadjuvant doxorubicin monotherapy

Bibliographic Details
Main Authors: Geisler, S, Smith-Sørensen, B, Betticher, D, Bukholm, IK, Akslen, LA, Kappeler, A, Gugger, M, Lønning, PE, Børresen-Dale, A-L
Format: Online
Language:English
Published: BioMed Central 2000
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300864/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300864/

Similar Items